PD-086 A phase II randomised study of gemcitabine-cisplatin (GP) vs mitomycin-ifosfamide-cisplatin (MIP) as neoadjuvant chemotherapy in resectable stage IIIA non-small cell lung cancer (NSCLC)
Brechot, J., Saintigny, P., Azorin, J., Valeyre, D., Breau, J., Morere, J., Gnom,Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80419-2
Date:
July, 2005
File:
PDF, 134 KB
english, 2005